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Background: Clostridium difficile toxins A and B (TcdA and TcdB), considered to be essential for C. difficile infection,
affect the morphology of several cell types with different potencies and timing. However, morphological changes
over various time scales are poorly characterized. The toxins’ glucosyltransferase domains are critical to their deleterious
effects, and cell responses to glucosyltransferase-independent activities are incompletely understood. By tracking
morphological changes of multiple cell types to C. difficile toxins with high temporal resolution, cellular responses
to TcdA, TcdB, and a glucosyltransferase-deficient TcdB (gdTcdB) are elucidated.
Results: Human umbilical vein endothelial cells, J774 macrophage-like cells, and four epithelial cell lines (HCT8, T84,
CHO, and immortalized mouse cecal epithelial cells) were treated with TcdA, TcdB, gdTcdB. Impedance across cell
cultures was measured to track changes in cell morphology. Metrics from impedance data, developed to quantify
rapid and long-lasting responses, produced standard curves with wide dynamic ranges that defined cell line sensitivities.
Except for T84 cells, all cell lines were most sensitive to TcdB. J774 macrophages stretched and increased in size in
response to TcdA and TcdB but not gdTcdB. High concentrations of TcdB and gdTcdB (>10 ng/ml) greatly reduced
macrophage viability. In HCT8 cells, gdTcdB did not induce a rapid cytopathic effect, yet it delayed TcdA and TcdB’s
rapid effects. gdTcdB did not clearly delay TcdA or TcdB’s toxin-induced effects on macrophages.
Conclusions: Epithelial and endothelial cells have similar responses to toxins yet differ in timing and degree. Relative
potencies of TcdA and TcdB in mouse epithelial cells in vitro do not correlate with potencies in vivo. TcdB requires
glucosyltransferase activity to cause macrophages to spread, but cell death from high TcdB concentrations is
glucosyltransferase-independent. Competition experiments with gdTcdB in epithelial cells confirm common TcdA
and TcdB mechanisms, yet different responses of macrophages to TcdA and TcdB suggest different, additional
mechanisms or targets in these cells. This first-time, precise quantification of the response of multiple cell lines to
TcdA and TcdB provides a comparative framework for delineating the roles of different cell types and toxin-host
interactions.
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Clostridium difficile infections, with an annual occurrence
in the US of over 300,000, cause potentially fatal diarrhea
and colitis [1]. These pathologies arise from the release
of two potent, homologous, protein toxins—TcdA and
TcdB—into the host gut. Another toxin, binary toxin, is
associated with higher patient fatality rates, yet binary
toxin alone is not sufficient to cause disease in animal
models [2,3]. The interactions of TcdA and TcdB with
many cell types lead to disease, yet the relative sensitiv-
ities and roles of different cell types remain poorly
understood. Both toxins disrupt the epithelial barrier by
causing epithelial cells to round and detach [4]. Neutro-
phil infiltration and activation of other immune cells,
driven by inflammatory signals, are also key to toxin-
induced enteritis [5]. Though several molecular media-
tors of disease have been identified, little is understood
about the host cell dynamics and the role of each cell
type involved [6,7]. To explore the toxins’ effects on
different cells, facets of the host response have been
studied using cell lines treated with TcdA and/or TcdB
(e.g., release of cytokines [6,8,9], changes in cell morph-
ology [10,11], gene expression [12,13], and cell death
[14,15]). Most of these assays used in previous studies
are limited to few time points, and since both toxins affect
cells rapidly (in less than one hour), it is unknown if either
toxin has additional effects on finer time scales and if any
of these effects are consistent across cell lines at compar-
able concentrations.
Assays or methods that record measurements with high
temporal frequency reveal small, but potentially important
changes that would go unnoticed in endpoint assays.
For example, live cell imaging or high-content screen-
ing methods produce near-continuous, sensitive readouts
of different cellular responses. We and others have tracked
temporal changes in cell morphology and attachment in
response to TcdA or TcdB by continuously measuring
electrical impedance across the surface of a cell culture
[16-18]. In this method, cells are grown on top of a bed of
electrodes covering a large portion of the surface of a
well. The media completes the circuit between electrodes.
When cells grow or increase their footprint or adher-
ence, electrical current cannot as easily pass between
electrodes and the electrical impedance rises. Cell
rounding, shrinking, and/or death decrease impedance.
It is important to note that impedance data alone does
not measure one particular cell interaction (e.g., growth,
adherence, spreading). Impedance is affected by a com-
bination of many variables. However, because of the
high sensitivity and precision provided, impedance data
has been used as a sensitive diagnostic to detect the
presence of a toxin—as a more quantitative replacement
of assays that are dependent on visualization of cell
rounding.In this study, we recognize that this impedance data,
in addition to indirectly detecting the amount of toxin in
samples, can further be analyzed to reveal previously
unrecognized, dynamic responses of host cells. Our ana-
lyses and associated metrics also allow precise comparisons
between the effects of TcdA and TcdB and between differ-
ent cell types. Using epithelial and endothelial cells, these
analyses identify characteristics such as the minimal ef-
fective toxin concentrations and the shortest time to
measurable toxin effects; standard curves with wide dy-
namic ranges can also be derived. Impedance changes
of other cells, such as macrophages, are not as easily
linked to known cell functions, but the data reveal toxin
effects that would not otherwise be observed at lower tem-
poral resolution. This understanding contextualizes the
potential roles and relative abilities of different cell types
to respond directly to toxin during an infection.
Impedance curves that profile cell responses also pro-
vide insight into the toxins’ molecular functions. TcdA and
TcdB have glucosyltransferase domains that inactivate
small GTPases. With the use of engineered mutant toxins,
glucosyltransferase activity has been found necessary
for cell rounding [19]. However, evidence that some
glucosyltransferase-deficient mutants of TcdB (gdTcdB)
are cytotoxic has raised questions about whether there
are other, previously unknown toxin activities [20]. In
order to identify changes dependent and independent
of glucosyltransferase activity, we use gdTcdB to evalu-
ate the dynamics of the response of macrophage and an
epithelial cell line to gdTcdB. We also leverage the unique
response profiles to TcdA, TcdB, and gdTcdB in order to
investigate synergy or antagonism between toxins.
The cell response profiles define the dynamics of basic
changes in cell physiology (e.g., cell rounding) across mul-
tiple cell types in response to TcdA, TcdB, and gdTcdB.
This understanding identifies those times most represen-
tative of the entire cell response, delineates the contribu-
tion of glucosyltransferase activity to overall toxin effects,




Our experiments include HUVECs, CHO cells, HCT8
cells, T84 cells, or an immortalized, cecal, mouse epithe-
lial cell line (hereon referred to as IMCE cells). HCT-8
cells were cultured in RPMI-1640 supplemented with
10% heat-inactivated fetal bovine serum (HI-FBS) and
1 mM sodium pyruvate. J774A.1 cells were cultured in
DMEM high glucose media supplemented with 10% HI-
FBS, 1 mM sodium pyruvate, and MEM nonessential
amino acids (Gibco 11140). HUVEC cells (passage 3) were
cultured in endothelial growth medium (EGM-Bullet Kit
CC-3124, Lonza group). T84 cells were grown in an equal
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media supplemented with 2.5 mM L-glutamine and 5%
HI-FBS. All cells were incubated at 37°C/5% CO2. In our
analyses, we include our previous data from IMCE cells
which were derived by Becker et al. and incubated at 33°C
as described previously [18,21]. For experiments with
neutrophils (Additional file 1), procedures were approved
by the University of Virginia Institutional Review Board
for Health Science Research and each donor gave written
consent. TcdA and TcdB, isolated and purified from strain
VPI-10463, were a generous gift from David Lyerly
(TECHLAB Inc., Blacksburg, VA). Recombinant gdTcdB
(D286N/D288N) and TcdB were a generous gift from the
laboratory of Aimee Shen. All reported results are from
experiments using native TcdB. The cytopathic effects
of recombinant TcdB was confirmed using HCT-8 cells
(Additional file 1).
Electrical impedance assay
Impedance was measured using the xCELLigence RTCA
system (ACEA Biosciences), which consists of an RTCA
DP Analyzer and 16-well E-plates. PBS was added around
all wells to prevent evaporation. In each well, 100 μL
media was incubated at room temperature for 30 minutes,
and one baseline reading was taken. Cells in 100 μL
media were then added and allowed to settle at room
temperature for 30 minutes. Cells were allowed to grow
directly on electrodes, without coating, in order to pro-
vide the most direct measurement of changes in cell
morphology and/or adherence. Plates were then moved
inside the RTCA DP Analyzer inside a CO2 incubator
at 37°C. Subsequent readings were taken at frequencies
ranging between every 4 seconds to every 10 minutes,
with higher frequency measurements reserved for times
directly before toxin addition to at least 6 hours after
addition (complete protocols and data files available in
the Additional file 1).
Since the impedance measurements are sensitive to
slight movements or vibrations, the method by which
toxin was added to cells was an important consideration.
In our initial experiments, mechanical agitation and re-
placement of media sometimes caused small, sharp spikes
in electrical impedance. To minimize disturbances, plates
were not removed from the RTCA Analyzer once the ex-
periment was begun. Toxins prepared in media (10x) were
gently pipetted using only one or two depressions. Media
was not replaced after the addition of toxin.
Cell viability
Viability was assessed by the ability of cells to metabolize
a colorless tetrazolium salt to formazen, an orange-colored
product (Cell Counting Kit-8 from Dojindo Molecular
Technologies). In accordance with the manufacturer’s in-
structions, 10 μL of CCK-8 solution was added to 100 μLwells and incubated for 1 h before measuring the absorb-
ance at 450 nm. Viability is reported as the percentage of
signal of untreated cells. Lysed cells did not produce any
signal.
Analyses
The protocols, data, computer code, and instructions for
running the code that reproduce all results and figures
are provided in the Additional file 1. Due to the volume
of data (thousands of points measured along each of
several curves), the standard deviation is visualized as
shaded regions.
Results
Quantification of the cytopathic effects elicited by TcdA
and TcdB
In order to assess the cytopathic effects of TcdA and
TcdB, we measured changes in impedance across the sur-
face of electrode-embedded wells (Methods). Impedance
is dependent upon cell number, adherence, and morph-
ology. It increases as cells proliferate or spread, and it de-
creases when toxin is added and cells round up (Figure 1).
The rate at which impedance decreases is dependent on
the toxin, toxin concentration, and cell type (Figure 2A,
B). To summarize the data-rich “impedance curves”, we
calculated simple metrics: the area between the curves of
control and toxin-treated cells (ABC, gray area in inset
of Figure 1) and the maximum slope of a curve (MaxS,
Figure 1). Both metrics produce log-linear calibration
curves (Figure 2C). A negative ABC indicates that the
impedance curves of toxin-treated cells are below the
curves of untreated cells. Blue, dashed lines in Figure 2C
show the variability of the ABC of control cells from
their average impedance curve. Standard curves relating
the time for impedance to drop by 50% (TD50) to toxin
concentration have been generated before [22], yet we
found that small experimental error in recording times
at which toxin was added directly translated to errors
in TD50. However, MaxS was more consistent between
replicates. In simpler terms, for replicates within and
between experiments, the time required to observe a
change in impedance was more variable than the rate
of that change. The other metric, ABC, captures long-
term effects by integrating readings over several hours.
The minimal concentration to induce an observable change
in impedance from control is denoted as the minimal cyto-
pathic concentration (MCC; Figure 2C). When ABC and
MaxS are considered together, toxin concentration can be
determined with a dynamic range spanning six orders of
magnitude or more (depending on toxin and cell type). To-
gether, these metrics allow for thousands of data points and
hundreds of wells to be simultaneously visualized and sum-
marized to dozens or fewer of numbers that can be easily




































































Figure 1 Measurement of toxins’ cytopathic effects by tracking electrical impedance across the surface of a cell culture. All impedance
readings were divided by the impedance at the time toxin was added (normalized impedance). Shaded regions above and below lines represent
the standard deviation of technical replicates (n = 2). Readings were taken as quickly as every four seconds (Methods). The brightness of each
photograph was adjusted digitally (uniformly across an entire photograph) to make the overall brightness across all photographs similar.
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responses but different sensitivities to TcdA and TcdB
In the first set of comparisons, we chose four well-
characterized cell types or cell lines—one endothelial
(HUVECs) and three epithelial (CHO, HCT8, and T84)—
and one immortalized, cecal, mouse epithelial cell line
(IMCE, see Methods). For these five cell lines, the MCC
for TcdA and TcdB varied over ranges of 0.1-1 ng/ml and
0.1-100 pg/ml, respectively (Figure 2D). We did not find a
maximal effective concentration of either toxin (1 μg/ml
was the highest concentration tested). TcdB was consist-
ently 100–1000 times more potent than TcdA, except in
T84 cells, which were equally sensitive to TcdA and TcdB
(as measured by MCC). The curves were largely similar in
that they all consisted of a short delay followed by a sharp
decrease that then leveled off (Figure 2A); differences were
primarily in scale. Determining the time to the onset of
the first toxin effects was complicated slightly by the phys-
ical process of adding toxins to wells—a process which
caused disturbances that temporarily affected impedance
(note the early “bump” in Figure 2A). Nevertheless, differ-
ences between control and toxin-treated cells can be dis-
tinguished. Across all cell types, the time required for an
impedance curve to diverge from control was more than
ten minutes. Nothing clearly suggested an immediate re-
sponse to toxin binding. Morphological changes might not
occur until after toxins enter cells and act intracellularly.
We next examined early effects of toxins on macrophagesand investigated the contribution of glucosyltransferase
activity to the dynamics of cell responses.
Macrophages: rapid, sensitive, complex concentration-
dependent responses to TcdA and TcdB
J774 mouse macrophages were as sensitive and respon-
sive to TcdA and TcdB as epithelial cells. The impedance
of macrophages treated with TcdA (300 ng/ml) and TcdB
(10 ng/ml) diverged from controls in 10 and 20 minutes,
respectively (Additional file 1). In contrast to epithelial
cells, however, the impedance of macrophages increased
after toxin addition (Figure 3), and the responses of J774
cells to TcdA and TcdB differed in shape and scale. TcdA
caused a rise in impedance at 0.1 ng/ml, and the magni-
tude and speed of this rise increased until TcdA con-
centration reached 100 ng/ml (Figure 3A). The elevated
impedance correlated with spreading and protrusions
from macrophages (Figure 3C). At higher concentrations
(300 and 1000 ng/ml), the slope of the rise continued
to increase, yet the rise was inhibited, as if stopped pre-
maturely before reaching its peak, and then impedance
dropped below that of control cells (Figure 3A and
Additional file 1). This decrease at 24 h correlated with
a loss of viable cells (Figure 3C). The unexplained, in-
creased viability at 4 h may be due to altered metabol-
ism of J774 cells. TcdB at 0.1, 1, and 10 ng/ml caused
impedance to rise and stabilize at approximately double
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Figure 2 Quantification of cytopathic effects. (A and B) The cytopathic effects between cell types and toxins can easily be distinguished.
(C) The impedance curves can be analyzed to produce two metrics, ABC and MaxS, which can then be used to define the minimal cytopathic
concentration (MCC). (D) The MCC of TcdA and TcdB for five cell lines define cell line specific sensitivities.
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and Additional file 1). Like TcdA, cell spreading corre-
lated with elevated impedance. Unlike TcdA, the con-
centrations of TcdB that caused increased impedance
did not result in any loss of viable cells (Figure 3C).
At 100 and 1000 ng/ml of TcdB, the impedance curves
were entirely different than lower concentrations. Instead
of rising, impedance fell. This characteristic correlated
with a loss of viability (Figure 3C). Hence, at or between
10 and 100 ng/ml, the response of macrophages to TcdB
switches from cell stretching and increased adherence to a
degradation of cell structure and loss of viability.
TcdB glucosyltransferase activity is required for full
cytopathic effects in HCT8 epithelial cells
Since the cytopathic effects of TcdA and TcdB have been
attributed to their glucosyltransferase activities, we
expected that gdTcdB would not cause cell rounding.
Indeed, the responses of HCT8 cells treated with
gdTdcB-treated (100 and 1000 ng/ml) and untreated cells
were indiscernible in the first ten hours after toxin addition(Figure 4A, B). After five days, gdTcdB at 1000 ng/ml
did eventually cause cytopathic effects (Additional file 1).
However, it is not clear if such a slow effect is
glucosyltransferase-independent or is due to residual
toxin activity. Nevertheless, glucosyltransferase activ-
ity is required for the full, rapid cytopathic effect of
TcdB in HCT8 cells.A glucosyltransferase-independent TcdB mechanism
decreases macrophage viability
We next determined glucosyltransferase-dependent toxin ef-
fects on J774 macrophages. gdTcdB at 1 ng/ml did not cause
macrophages to change their morphology as did TcdB
(Figure 5A). At 10 ng/ml, gdTcdB slightly raises imped-
ance, yet the overall structure and viability of cells was
similar to untreated cells (Figure 5A, B). However, gdTcdB
at 100 ng/ml resulted in a loss of intact and viable macro-
phages, similar to TcdB at 100 ng/ml (Figures 3B, C
and 5B). Hence, glucosyltransferase activity is required
for macrophage stretching. However, at or above 100 ng/ml,
A B





































































Figure 3 Macrophage responses to TcdA and TcdB. (A and B) Impedance curves from a range of TcdA and TcdB concentrations. Both graphs
represent one experiment where confluent cells were treated with toxin (replicate experiments shown in Additional file 1). (C) Replicates
experiments were performed in transparent wells for brightfield microscopy. The viability of cells as measured by the CCK-8 assay (Methods) is
shown in the bar charts beneath the microscopy images.
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triggers a rapid loss of viability in J774 macrophages.gdTcdB delays TcdA’s effects in epithelial cells
To investigate if TcdA and TcdB have overlapping activ-
ity, we performed experiments with gdTcdB plus TcdA
or TcdB. We anticipated that gdTcdB would attenuate or
delay the effects of TcdB and perhaps TcdA. Indeed, a
tenfold excess gdTcdB delayed the onset of the effects of
TcdA and TcdB in HCT8 cells (Figure 4A, B).
With J774 macrophages, gdTcdB in 100-fold excess
did not clearly delay the effects of TcdB at 0.1 ng/ml
(Figure 4D). In two other experiments, the average rise
in impedance with gdTcdB + TcdB was delayed from the
rise with TcdB alone, yet the short duration of the delay
(5–15 minutes) and the variability of replicates made it
difficult to definitively show that gdTcdB delays the effects
of TcdB in J774 macrophages (Additional file 1). Higher
gdTcdB concentrations could not be used since they
would decrease cell viability (Figure 3C). gdTcdB did
not delay the effects of TcdA (Figure 4C).Discussion
In this study we systematically profiled the dynamic re-
sponses of epithelial, endothelial, and macrophage cell
lines to TcdA and TcdB, revealing relative sensitivities and
complex concentration-dependent cell responses. The im-
pedance “response profiles” provide continuous readouts
representing external changes in morphology and adher-
ence that occur from a combination of several changes
within the cell. We explored how glucosyltransferase ac-
tivity contributes to these changes by using gdTcdB. The
response profiles raise many questions about the mecha-
nisms for the differences we observed. Although address-
ing each of these in detail is beyond the scope of this
study, we highlight, in the following text, the findings that
bring about these questions, discuss their relevance to pre-
vious studies, and explain how they improve our current
understanding of host cell responses to TcdA and TcdB.
The cytopathic effects of TcdA and TcdB are the gold
standard diagnostic for infection [23,24]. However, the
kinetics of these effects have typically been characterized
at a limited number of time points. With a continuous






























































































Figure 4 Response of HCT8 epithelial cells and J774 macrophages to TcdA + gdTcdB, and TcdB + gdTcdB. (A-B) Confluent HCT8 cells
treated with toxins (see Additional file 1 for replicate experiments). (C-D) Confluent J774 cells treated with toxins (see Additional file 1 for replicate
experiments).
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the cell surface, the morphological differences (represented
by impedance) occurred after a delay of ten minutes or
more. Since TcdA (2.65 μg/ml) has been found to enter
HT29 cells in 5–10 minutes, the delay we observed is likely
because toxins must enter HCT8 cells to alter their
morphology [25]. Also, in our experiments with more
than one toxin, gdTcdB often delayed the onset of cyto-
pathic effects by one hour or less. Without high tem-
poral resolution, we would have likely missed the time
window in which TcdB + gTcdB was different than TcdB
alone. Hence, without precisely tracking changes in cell
impedance, several molecules or proteins that delay or
accelerate toxin effects could be missed.
Epithelial and endothelial cell lines had similar mor-
phological changes, yet the rapidity of the changes dis-
tinguished different cell types, toxin concentrations, and
TcdA versus TcdB. These differences could be summarized
by condensing the data into metrics that represented the
greatest rate of the change (MaxS) and the cumulative
amount of change over several hours (ABC). When these
metrics are considered together, standard curves over
many orders of magnitude can be used to measure toxin
concentration and determine the minimal amount of toxin
necessary to induce an effect (Figure 2D). The CHO cell
line was second-most sensitive to TcdB, making CHO
cells a good choice for toxin detection. Indeed, a modi-
fied CHO cell line was used in the development of anultrasensitive assay of toxin activity [16]. T84 cells, the
least sensitive to TcdB, were similarly sensitive to TcdA
and TcdB, as has been found previously [26]. For TcdB,
the two rodent cell lines (CHO and IMCE) were more
sensitive than the three human cell lines (HCT8, HUVEC,
and T84), although more cell lines would be needed to
confirm any species-specific sensitivity. For TcdA, cell line
sensitivities were less variable than for TcdB, indicating
that factors that make cells vulnerable to TcdA may be
more consistent between cell lines.
Comparisons between TcdA and TcdB have often been
a prominent research focus. TcdB is more cytotoxic in
cell culture; TcdA is more enterotoxic in animal intoxica-
tion models [18,27]; and there are varying results about
which toxin is essential for C. difficile infection [28,29]. By
correlating differences in host cell responses to differences
in disease severity, particular cell types or toxin activities
can be prioritized. For instance, TcdA is more enterotoxic
than TcdB in mice and hamster ceca [18,30]. This obser-
vation agrees with findings that TcdA binds more strongly
than TcdB in the hamster intestine [31,32]. One might
then expect that cecal epithelial cells from mice of the
same genetic background as those used in the aforemen-
tioned in vivo studies (IMCE cells) would be more sensi-
tive to TcdA than TcdB. Instead, IMCE cells were over
100 times more sensitive to TcdB than TcdA, suggesting
that factors in addition to the cytopathic effects on epithe-
lial cells are important in explaining the pathologies of











































Figure 5 Macrophage responses to TcdA and TcdB. (A) Changes
in impedance and of confluent J774 cells in response to gdTcdB
and TcdB (B) A replicate experiment in transparent wells for
brightfield microscopy and viability assays. Controls are the same as
in Figure 3.
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types may be the key mediators determining disease
severity.
Previous studies have quantified the viability of either
TcdA- or TcdB-treated macrophages at one or two time
points [33-35]. In our results, TcdA or TcdB rapidly in-
duced macrophages to increase adherence and/or spread.
After 24 h or more of TcdA or TcdB (10 ng/ml or less)
treatment, macrophages became larger and more circular.
The decreased impedance with TcdA was correlated with
a partial loss of viability. This result agrees in part with
Melo Filo et al. who reported that TcdA and TcdB killed
30% and 60%, respectively, of primary mouse macrophages
(1 μg/ml at 24 h) [33]. In our experiments with J774 cells,
TcdB-treated cells at 10 ng/ml or less remained viable, andTcdB-treated cells at or above 100 ng/ml lossed nearly all
viability. The balance of morphological changes and in-
creased adherence versus death likely account for the
complex rise and fall of impedance in toxin-treated
macrophages.
TcdB caused two distinct responses in J774 macro-
phages: stretching (≤10 ng/ml) or a loss of viability
(≥100 ng/ml). Siffert et al. showed TcdB-treated, human
macrophages “arborize”, or stretch, with little loss of
viability (1 μg/ml at 3 h and 24 h) [34]. It is possible
that TcdB also causes two distinct responses in human
macrophages, but Siffert et al. only reported results at
one concentration. Although much remains to be deter-
mined about the mechanisms of these effects, early stimu-
lation of macrophages may be associated with acute
inflammation, while eventual death correlates with macro-
phage depletion and neutrophil accumulation in C. diffi-
cile-associated diarrhea [36].
The cell responses described above prompted ques-
tions about potential responses that are independent of
the toxins’ glucosyltransferase activity. Only after several
days were we able to observed cytotoxic or cytopathic
effects of gdTcdB in HCT8 cells. Chumbler et al. found
that glucosyltransferase mutants were cytotoxic to HeLa
cells after only 2.5 h [20]. The different cell types (HCT8
versus HeLa) and different glucosyltransferase mutants
may account for the differences in timing. The effects of
mutant toxins have never been assessed over such long
time scales with such great sensitivity.
Since TcdA and TcdB are homologous, one might ex-
pect that gdTcdB should interfere with TcdA. Indeed, in
HCT8 cells, gdTcdB delayed the cytopathic effects of
TcdA and TcdB. Although impedance data alone do not
show that a direct or toxin-specific molecular interaction
is responsible for the delay, one possible interpretation
of this result is that TcdA and TcdB compete for cell
entry. However, two studies using truncated toxins found
that the C-termini of each toxin (believed to be necessary
for internalization) do not inhibit internalization of the
other toxin [37,38]. Since the glucosyltransferase domains
of TcdA and TcdB share substrates, another possible inter-
pretation is that the toxins compete after internalization.
Indeed, blocking glucosyltransferase activity would reduce
the cytopathic effects as is shown with gdTcdB. However,
as described below, glucosyltransferase activity may not be
required for all toxin effects in all cell types.
Since macrophages detect a variety of antigens, one
might expect that the responses to toxin might not be
entirely dependent on glucosyltransferase activity. The
stretching of macrophages with TcdB concentrations at
or below 10 ng/ml required glucosyltransferase activity.
However, TcdB at or above 100 ng/ml destroyed macro-
phage structure by an unknown, glucosyltransferase-
independent mechanism.
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and macrophages to TcdA and TcdB suggests they could
be damaged by direct toxin interaction in the host. How-
ever, the location of toxin during infection is poorly
understood. With sensitivities of cells reaching as low as
100 pg/ml, tracking toxins by immunohistochemistry is
technically challenging [32]. Assessing sensitivities in vitro
provides an indirect measure of the roles of cell types in
isolation. Additionally, TcdA and TcdB initiate a cascade
of deleterious events involving multiple cells. Neuronal
signals have been implicated in beginning the disease
process, stimulating mast cells or macrophages that may
then recruit other cells [39-42]. Neutrophil infiltration is a
hallmark of intoxication, yet neutrophils in vitro require
much higher toxin concentrations to be recruited
(>1 μg/ml) [43-45]. To confirm the low sensitivity of
neutrophils, we attempted to measure impedance changes
of neutrophils in response to toxins, yet the variability in
these primarily non-adherent cells was too high to identify
differences (Additional file 1). Elements of the toxin
responses of other cell types (e.g., mast cells [46-48],
dendritic cells [49,50], neurons [51,52], fibroblasts [53,54],
etc.) have been studied, yet the dynamics of their re-
sponses—and in some cases concentration-dependent
effects—are unknown. In the future, precisely capturing
the time and concentration-dependent responses to TcdA
and TcdB will better contextualize their potential roles in
the host.Conclusions
Our analyses of endothelial cells, epithelial cells, and
macrophages in the same experimental framework set a
precedent for high-temporal resolution comparisons of
the effects of Clostridium difficile TcdA and TcdB. We
precisely determine the relative sensitivity of various epi-
thelial cell lines, showing an overall greater TcdB sensi-
tivity with few exceptions. Interestingly, an immortalized
mouse epithelial cell line is more sensitive to TcdB al-
though mice injected with toxin are more sensitive to
TcdA. Using gdTcdB, we found that glucosyltransferase
activity is necessary for the rapid cytopathic effects of
HCT8 epithelial cells or the rapid spreading of J774
macrophage-like cells. However, the ability of gdTcdB to
decrease J774 cell viability indicates a glucosyltransferase-
independent mechanism contributes to cell death. Add-
itionally, responses of J774 cells to TcdA and TcdB were
characteristically different, suggesting important differ-
ences in toxin mechanism and/or targets in these cells.
In the future, the framework and simple analyses in this
study may also be used to investigate synergy, antagon-
ism, or interactions between bacterial toxins and other
host factors that affect cells over a wide range of time
scales.Additional file
Additional file 1: Supplement.
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